Elise Meima-van Praag on surgical closure for Crohn’s disease perianal fistulas

The Lancet Gastroenterology & Hepatology in conversation with - A podcast by The Lancet Group

Categories:

Education

Elise Meima-van Praag (Amsterdam University Medical Centre) discusses the PISA-II trial, investigating short-term anti-TNF therapy with surgical closure versus anti-TNF therapy for perianal fistulas in Crohn's disease. Read the full article: Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II) Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/t...